Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chamaida Plasencia
Observed names:
C Plasencia,
C. Plasencia,
C.H. Plasencia,
CH Plasencia,
Ch Plasencia,
Ch. Plasencia,
Plasencia, Chamaida
show all 7
Institutions:
Hospital Universitario La Paz,
Hospital La Paz Institute for Health Research
Observed institutions:
Hospital Universitario La Paz,
Sanquin,
Reade,
Hospital La Paz Institute for Health Research,
University of Amsterdam
ORCID:
0000-0003-3503-9047
Observed ORCID:
0000-0003-3503-9047
OpenAlex ID:
A5113858719
Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis
2011
·
D. Pascual-Salcedo
, C. Plasencia
, et al.
·
Rheumatology
·
259
Influence of immunogenicity on the efficacy of longterm treatment of spondyloarthritis with infliximab
2012
·
Chamaida Plasencia
, Dora Pascual-Salcedo
, et al.
·
Annals of the Rheumatic Diseases
·
122
Constitutively altered frequencies of circulating follicullar helper T cell counterparts and their subsets in rheumatoid arthritis
2014
·
Irene Arroyo-Villa
, María-Belén Bautista-Caro
, et al.
·
Arthritis Research & Therapy
·
98
PDF
Antibodies to infliximab in Remicade-treated rheumatic patients show identical reactivity towards biosimilars
2016
·
M Begoña Ruiz-Argüello
, Ainara Maguregui
, et al.
·
Annals of the Rheumatic Diseases
·
80
False positives in the ultrasound diagnosis of giant cell arteritis: some diseases can also show the halo sign
2019
·
Elisa Fernández-Fernández
, Irene Monjo-Henry
, et al.
·
Rheumatology
·
75
The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
2013
·
Chamaida Plasencia
, Dora Pascual-Salcedo
, et al.
·
Arthritis Research & Therapy
·
74
PDF
Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis
2020
·
Marta Novella-Navarro
, Chamaida Plasencia
, et al.
·
Arthritis Research & Therapy
·
52
PDF
Serum tocilizumab trough concentration can be used to monitor systemic IL-6 receptor blockade in patients with rheumatoid arthritis: a prospective observational cohort study
2016
·
EL Kneepkens
, IAM van den Oever
, et al.
·
Scandinavian Journal of Rheumatology
·
43
PDF
Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity
2015
·
Chamaida Plasencia
, Eva L. Kneepkens
, et al.
·
The Journal of Rheumatology
·
36
PDF
Golimumab trough levels, antidrug antibodies and clinical response in patients with rheumatoid arthritis treated in daily clinical practice
2014
·
Eva L Kneepkens
, Chamaida Plasencia
, et al.
·
Annals of the Rheumatic Diseases
·
33
Enthesis erosion in spondyloarthritis is not a persistent structural lesion
2011
·
Eugenio de Miguel
, Sandra Falcao
, et al.
·
Annals of the Rheumatic Diseases
·
29
Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid Arthritis
2017
·
Frédéric Medina
, Chamaida Plasencia
, et al.
·
Therapeutic Drug Monitoring
·
28
Unveiling axial involvement in psoriatic arthritis: An ancillary analysis of the ASAS-perSpA study
2021
·
D. Benavent
, Ch. Plasencia
, et al.
·
Seminars in Arthritis and Rheumatism
·
25
El uso de abatacept en artritis reumatoide: revisión de la evidencia y recomendaciones
2013
·
Emilio Martín Mola
, Alejandro Balsa
, et al.
·
Reumatología Clínica
·
23
Doppler enthesitis: a potential useful outcome in the assessment of axial spondyloarthritis and psoriatic arthritis
2020
·
Juan Molina Collada
, Cristina Macía-Villa
, et al.
·
Clinical Rheumatology
·
20
Infusion reactions during infliximab treatment are not associated with IgE anti-infliximab antibodies
2017
·
Karin A van Schie
, Pleuni Ooijevaar-De Heer
, et al.
·
Annals of the Rheumatic Diseases
·
17
Pathogenic mechanisms involving the interplay between adipose tissue and auto-antibodies in rheumatoid arthritis
2022
·
Iván Arias-de la Rosa
, Alejandro Escudero-Contreras
, et al.
·
iScience
·
14
Cost evolution of biological agents for the treatment of spondyloarthritis in a tertiary hospital: influential factors in price
2018
·
Mariángeles González-Fernández
, Elena Villamañán
, et al.
·
International Journal of Clinical Pharmacy
·
13
Comparison study of two commercially available methods for the determination of golimumab and anti-golimumab antibody levels in patients with rheumatic diseases
2015
·
Sergio Martín
, Ainhoa Ruiz del Agua
, et al.
·
Clinical Chemistry and Laboratory Medicine (CCLM)
·
12
Effect of Infliximab Dose Increase in Rheumatoid Arthritis at Different Trough Concentrations: A Cohort Study in Clinical Practice Conditions
2015
·
Chamaida Plasencia
, Teresa Jurado
, et al.
·
Frontiers in Medicine
·
11
PDF
Abatacept Use in Rheumatoid Arthritis: Evidence Review and Recommendations
2012
·
Emilio Martín Mola
, Alejandro Balsa
, et al.
·
Reumatología Clínica (English Edition)
·
11
Op0210 False Positives of Ultrasound in Giant Cell Arteritis. Some Diseases Can Also Have Halo Sign
2019
·
Elisa Fernández
, Irene Monjo
, et al.
·
Annals of the Rheumatic Diseases
·
10
PDF
Color Doppler and spectral Doppler ultrasound detection of active sacroiliitis in spondyloarthritis compared to physical examination as gold standard
2017
·
Concepción Castillo-Gallego
, Eugenio De Miguel
, et al.
·
Rheumatology International
·
10
Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Spondyloarthritis
2017
·
Frédéric Medina
, Chamaida Plasencia
, et al.
·
Therapeutic Drug Monitoring
·
10
The timing of serum infliximab loss, or the appearance of antibodies to infliximab (ATI), is related with the clinical activity in ATI-positive patients with rheumatoid arthritis treated with infliximab
2013
·
Ch Plasencia
, D Pascual-Salcedo
, et al.
·
Annals of the Rheumatic Diseases
·
9
Show more works
View as search
Works count:
152
Citation count:
1,207
H-index:
16
I10-index:
24
Year
Topic
Type
